Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Drug Discovery and Development Solutions Market Outlook

The global drug discovery and development solutions market is expected to grow at a CAGR of 13% in the forecast period of 2024-2032.

Global Drug Discovery and Development Solutions Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for the Drug Discovery and Development Solutions Industry

The global market for drug discovery and development solutions is significantly aided by the industry growth in North America. The development of the drug discovery outsourcing industry in the region could be attributed to an increase in emphasis on discovering medicines for the treatment of COVID-19, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the growth of the drug discovery and development solutions industry.

Drug Discovery and Development Solutions: Market Segmentation

Drug discovery refers to the discovery of new medication and to the process of creating a therapeutically active substance for a particular target molecule or pathway. Drug discovery comprises of screening hits, medicinal chemistry, and optimisation of hits to reduce possible side effects of drugs. The discovery and development solutions of drugs together is a full process of identifying and introducing a new medication in the market.

Global Drug Discovery and Development Solutions Market By Service Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The service types in the market can be divided into the following:

The drug types in the market can be divided into small molecules and biologics. The process types can be segmented as:

  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimisation
  • Candidate Validation
  • Others

The technology types in the industry can be segmented into the following:

  • High Throughput Screening
  • Biochips
  • Pharmacogenetics
  • Nanotechnology
  • Spectroscopy
  • Others

Based on therapeutic area, the market can be segmented into:

  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Others

The regional markets for drug discovery and development solutions can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Drug Discovery and Development Solutions Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising R&D Activities in the Pharmaceuticals Sector Bolstering the Market Growth for Drug Discovery and Development Solutions 

The expansion of the demand for drug discovery outsourcing can be attributed to an increase in the emphasis on discovering medicines for the treatment of the rising COVID-19 pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the market growth. Developments in fundamental algorithms are used in computational information processing for predictive chemistry, which leads to improvements in scientific innovation and laboratory informatics. This is likely to increase the demand in the market in the coming years.

Key Industry Players in the Global Drug Discovery and Development Solutions Market

The report gives a detailed analysis of the following key players in the global drug discovery and development solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott Laboratories Inc.
  • AstraZeneca plc
  • Genentech, USA Inc
  • Charles River Laboratories International, Inc.
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Jubilant Biosys Ltd.
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Service Type
  • Drug Type
  • Process
  • Technology
  • Mode
  • Therapeutic Area
  • End Use
  • Region
Breakup by Service Type
  • Medicinal Chemistry
  • Biology Services
  • Drug Metabolism 
  • Pharmaceutical Services
  • Pharmacokinetics
  • Others
Breakup by Drug Type
  • Small Molecules
  • Biologics
Breakup by Process
  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimisation
  • Candidate Validation
  • Others
Breakup by Technology
  • High Throughput Screening
  • Biochips
  • Pharmacogenetics
  • Nanotechnology
  • Spectroscopy
  • Others
Breakup by Mode
  • In-house
  • Outsourced
Breakup by Therapeutic Area
  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Others
Breakup by End Use
  • Hospital & Clinics
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institute
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abbott Laboratories Inc.
  • AstraZeneca plc
  • Genentech, USA Inc
  • Charles River Laboratories International, Inc.
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Jubilant Biosys Ltd.
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 13% between 2024 and 2032.

The growth of the market is being driven by the growing population, expanding healthcare sector, increasing disposable incomes, and the thriving pharmaceuticals sector.

The increasing demand for outsourcing analytical testing services and growing research and development activities are the key trends guiding the growth of the market.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different service types in the market are medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others.

The major drug types in the market are small molecules and biologics.

The significant processes in the market are target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others.

The various technology types in the market are high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others.

The major therapeutic areas in the market are oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others.

The major players in the global drug discovery and development solutions market are Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124